| HCVAX | OCGCX | HCVAX / OCGCX | |
| Total Expense Ratio | 1.01 | 1.42 | 71% |
| Annual Report Gross Expense Ratio | 1.01 | 1.42 | 71% |
| Fund Existence | 22 years | 29 years | - |
| Gain YTD | 1.006 | 0.940 | 107% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2000 | 500 | 400% |
| Min. Initial Investment IRA | 2000 | N/A | - |
| Net Assets | 143M | 4.43B | 3% |
| Annual Yield % from dividends | 3.15 | 2.74 | 115% |
| Returns for 1 year | 10.61 | 8.13 | 131% |
| Returns for 3 years | 27.31 | 19.43 | 141% |
| Returns for 5 years | 15.84 | 7.97 | 199% |
| Returns for 10 years | 64.66 | 33.77 | 191% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AIVOX | 12.83 | 0.18 | +1.42% |
| American Century International Opps A | |||
| VSFCX | 23.42 | 0.07 | +0.30% |
| Federated Hermes MDT Small Cap Value C | |||
| JFNIX | 81.99 | -0.52 | -0.63% |
| Janus Henderson Global Life Sciences I | |||
| RYEUX | 128.58 | -1.83 | -1.40% |
| Rydex Europe 1.25x Strategy H | |||
| SLRYX | 41.66 | -0.67 | -1.58% |
| SEI Large Cap Growth Y (SIMT) | |||